Clinical Trials Browser

Phase 1/2 × Pancreatic Cancer Metastatic × sintilimab × Clear all

NCT06888648 2025-03-21

Personalized Tumor Neoantigen MRNA Therapy for Advanced Pancreatic Cancer.

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Metastatic